已收盘 11-20 16:00:00 美东时间
-3.130
-2.17%
Sanofi weighs potential Insmed acquisition to offset Dupixent patent loss, prompting analysts to weigh respiratory synergy against deal cost and capacity.
今天 01:14
Insmed (INSM) stock surges over 18% after reports that French pharma giant Sanofi (SNY) is exploring a potential takeover.
11-20 02:57
https://www.bloomberg.com/news/articles/2026-11-19/sanofi-weighs-takeover-of-us-drugmaker-insmed
11-19 23:17
Insmed reports 12-month TPIP extension data showing sustained efficacy and favorable safety in PAH ahead of Phase 3 PALM-PAH.
07-17 02:32
William Blair starts Zura Bio (NASDAQ: ZURA) at Outperform, citing tibulizumab's multibillion-dollar potential in autoimmune disease.
07-09 01:24
CRWV stock climbs 5% as CoreWeave gears up to join the Nasdaq-100. Get the latest price action, inclusion details, and analysis.
06-12 18:41
This whale alert can help traders discover the next big trading opportunities. ...
05-26 01:35
Insmed halts HS program after CEDAR study miss; analysts cite trial challenges while focus shifts to Brinsupri and Arikayce growth drivers.
04-08 19:08
Insmed says Phase 3b Arikayce data show symptom and culture gains in lung infection patients, analyst backs approval.
03-24 00:24